Paydirt
BL
Insider

Baker Brothers Life Sciences LP

Director

Baker Brothers Life Sciences LP (Director) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in BGNE. The largest single filing was $194.2M of BGNE (1,037,017 sh across 4 lots, as filed), executed Dec 9 2024.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$194.2M
shares × price, as filed
Last traded
Dec 9 2024
Filed Dec 10 2024
Open performance→
Volume by month
$194.2M$97.1M$0Oct 2024Apr 2025Oct 2025Apr 2026Dec 2024 · sells $194.2M
Buys $0 Sells $194.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 1 filing

Sector per market data · by filing · past 24 months

Most traded names
BGNE BGNE BGNE · 0 buys · 1 sell 1 filing
Recent filings
BGNESALE BeiGene, Ltd. View filing → $194.2M
1,037,017 sh across 4 lots
Exec Dec 9 2024
Filed Dec 10 2024 · 5:30 PM ET